IBDEI0YJ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15595,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,15595,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,15595,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,15596,0)
 ;;=F17.200^^61^760^52
 ;;^UTILITY(U,$J,358.3,15596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15596,1,3,0)
 ;;=3^Nicotine Dependence,Unspec
 ;;^UTILITY(U,$J,358.3,15596,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,15596,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,15597,0)
 ;;=G43.909^^61^760^50
 ;;^UTILITY(U,$J,358.3,15597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15597,1,3,0)
 ;;=3^Migraine,Unspec
 ;;^UTILITY(U,$J,358.3,15597,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,15597,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,15598,0)
 ;;=H91.93^^61^760^36
 ;;^UTILITY(U,$J,358.3,15598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15598,1,3,0)
 ;;=3^Hearing Loss,Bilateral
 ;;^UTILITY(U,$J,358.3,15598,1,4,0)
 ;;=4^H91.93
 ;;^UTILITY(U,$J,358.3,15598,2)
 ;;=^5006944
 ;;^UTILITY(U,$J,358.3,15599,0)
 ;;=I10.^^61^760^43
 ;;^UTILITY(U,$J,358.3,15599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15599,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,15599,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,15599,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,15600,0)
 ;;=I50.9^^61^760^19
 ;;^UTILITY(U,$J,358.3,15600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15600,1,3,0)
 ;;=3^Congestive Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,15600,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,15600,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,15601,0)
 ;;=I67.89^^61^760^18
 ;;^UTILITY(U,$J,358.3,15601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15601,1,3,0)
 ;;=3^Cerebrovascular Disease,Oth
 ;;^UTILITY(U,$J,358.3,15601,1,4,0)
 ;;=4^I67.89
 ;;^UTILITY(U,$J,358.3,15601,2)
 ;;=^5007388
 ;;^UTILITY(U,$J,358.3,15602,0)
 ;;=J45.909^^61^760^4
 ;;^UTILITY(U,$J,358.3,15602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15602,1,3,0)
 ;;=3^Asthma,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,15602,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,15602,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,15603,0)
 ;;=J44.9^^61^760^16
 ;;^UTILITY(U,$J,358.3,15603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15603,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,15603,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,15603,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,15604,0)
 ;;=K21.9^^61^760^31
 ;;^UTILITY(U,$J,358.3,15604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15604,1,3,0)
 ;;=3^GERD w/o Esophagitis
 ;;^UTILITY(U,$J,358.3,15604,1,4,0)
 ;;=4^K21.9
 ;;^UTILITY(U,$J,358.3,15604,2)
 ;;=^5008505
 ;;^UTILITY(U,$J,358.3,15605,0)
 ;;=N40.1^^61^760^29
 ;;^UTILITY(U,$J,358.3,15605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15605,1,3,0)
 ;;=3^Enlarged Prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,15605,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,15605,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,15606,0)
 ;;=L03.818^^61^760^17
 ;;^UTILITY(U,$J,358.3,15606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15606,1,3,0)
 ;;=3^Cellulitis,Oth Sites
 ;;^UTILITY(U,$J,358.3,15606,1,4,0)
 ;;=4^L03.818
 ;;^UTILITY(U,$J,358.3,15606,2)
 ;;=^5009064
 ;;^UTILITY(U,$J,358.3,15607,0)
 ;;=G47.33^^61^760^77
 ;;^UTILITY(U,$J,358.3,15607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15607,1,3,0)
 ;;=3^Sleep Apnea,Obstructive
 ;;^UTILITY(U,$J,358.3,15607,1,4,0)
 ;;=4^G47.33
 ;;^UTILITY(U,$J,358.3,15607,2)
 ;;=^332763
 ;;^UTILITY(U,$J,358.3,15608,0)
 ;;=R73.01^^61^760^46
